5am Partners Iv, Llc - Net Worth and Insider Trading
5am Partners Iv, Llc Net Worth
The estimated net worth of 5am Partners Iv, Llc is at least $11 Million dollars as of 2024-11-05. 5am Partners Iv, Llc is the 10% Owner of scPharmaceuticals Inc and owns about 2,734,852 shares of scPharmaceuticals Inc (SCPH) stock worth over $11 Million. 5am Partners Iv, Llc is also the 10% Owner of Pear Therapeutics Inc and owns about 200,000 shares of Pear Therapeutics Inc (PEARQ) stock worth over $20. Details can be seen in 5am Partners Iv, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that 5am Partners Iv, Llc has not made any transactions after 2023-04-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of 5am Partners Iv, Llc
5am Partners Iv, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, 5am Partners Iv, Llc owns 6 companies in total, including Aprea Therapeutics Inc (APRE) , Crinetics Pharmaceuticals Inc (CRNX) , and IDEAYA Biosciences Inc (IDYA) among others .
Click here to see the complete history of 5am Partners Iv, Llc’s form 4 insider trades.
Insider Ownership Summary of 5am Partners Iv, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2019-10-02 | 10 percent owner |
| CRNX | Crinetics Pharmaceuticals Inc | 2018-07-17 | 10 percent owner |
| IDYA | IDEAYA Biosciences Inc | 2020-11-11 | 10 percent owner & Former 10% holder |
 | | 2018-03-27 | 10 percent owner |
| | 2022-10-10 | 10 percent owner |
| | 2023-04-10 | 10 percent owner |
5am Partners Iv, Llc Latest Holdings Summary
5am Partners Iv, Llc currently owns a total of 2 stocks. Among these stocks, 5am Partners Iv, Llc owns 2,734,852 shares of scPharmaceuticals Inc (SCPH) as of October 10, 2022, with a value of $11 Million and a weighting of 100%. 5am Partners Iv, Llc also owns 200,000 shares of Pear Therapeutics Inc (PEARQ) as of April 10, 2023, with a value of $20 and a weighting of 0%.
Latest Holdings of 5am Partners Iv, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc | 2022-10-10 | 2,734,852 | 4.08 | 11,144,522 |
| PEARQ | Pear Therapeutics Inc | 2023-04-10 | 200,000 | 0.00 | 20 |
Holding Weightings of 5am Partners Iv, Llc
5am Partners Iv, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, 5am Partners Iv, Llc has made a total of 3 transactions in scPharmaceuticals Inc (SCPH) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in scPharmaceuticals Inc is the sale of 600,000 shares on October 10, 2022, which brought 5am Partners Iv, Llc around $2 Million.
According to the SEC Form 4 filings, 5am Partners Iv, Llc has made a total of 6 transactions in Pear Therapeutics Inc (PEARQ) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Pear Therapeutics Inc is the sale of 16,544,113 shares on April 10, 2023, which brought 5am Partners Iv, Llc around $2 Million.
Insider Trading History of 5am Partners Iv, Llc
- 1
5am Partners Iv, Llc Trading Performance
GuruFocus tracks the stock performance after each of 5am Partners Iv, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by 5am Partners Iv, Llc is 8.5%. GuruFocus also compares 5am Partners Iv, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by 5am Partners Iv, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how 5am Partners Iv, Llc's insider trading performs compared to the benchmark.
Performance of 5am Partners Iv, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.71 | | | | | |
| Relative Return to S&P 500(%) | -19 | | | | | |
5am Partners Iv, Llc Ownership Network
Ownership Network List of 5am Partners Iv, Llc
Ownership Network Relation of 5am Partners Iv, Llc
5am Partners Iv, Llc Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
5am Partners Iv, Llc is the 10 percent owner of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, 5am Partners Iv, Llc made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 3,900 shares made by Oren Gilad , a net purchase of 26,957 shares made by Bernd R. Seizinger , and a net purchase of 23,728 shares made by Marc Duey .
In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 69,417 shares were bought by its insiders, resulting in a net purchase of 62,955 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
5am Partners Iv, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for 5am Partners Iv, Llc. You might contact 5am Partners Iv, Llc via mailing address: 501 2nd Street, Suite 350, San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
